Status: Recruiting
Patisiran-Lipid Nanoparticle (LNP) Pregnancy Surveillance Program
The purpose of this study is to collect and evaluate pregnancy outcomes, pregnancy complications, and fetal/neonatal/infant outcomes in women exposed to patisiran-LNP.
Participants needed: 10
Trial details
Biological sex: FemaleType: ObservationalSponsor: Alnylam PharmaceuticalsUpdated: Jun 1, 2026Locations: 7
Eligibility criteria
Documentation that the patient was exposed to patisiran-LNP at any point startin...
There are no exclusion criteria for participation in this program.